Publication:
Insulin resistance, adipocyte biology, and thiazolidinediones: A review

dc.contributor.authorsTarcin O., Bajaj M., Akalin S.
dc.date.accessioned2022-03-15T01:55:51Z
dc.date.accessioned2026-01-11T09:33:09Z
dc.date.available2022-03-15T01:55:51Z
dc.date.issued2007
dc.description.abstractObesity is a well-recognized risk factor for the development of insulin resistance and the metabolic syndrome. Adipokines secreted from adipocytes play an important role in the pathogenesis of insulin resistance, hypertension, disorders of coagulation, dyslipidemia, and glucose abnormalities associated with insulin resistance or the metabolic syndrome. The selective ligands of the nuclear transcription factor PPARγ, Thiazolidinediones (TZDs), induce differentiation of preadipocytes to mature and more insulin sensitive adipocytes. This review summarizes adipocyte biology, the role of the adipokines in the pathogenesis of insulin resistance, and the effects of TZDs on insulin resistance and the metabolic disorders associated with it. © Mary Ann Liebert, Inc.
dc.identifier.doi10.1089/met.2007.0001
dc.identifier.issn15404196
dc.identifier.urihttps://hdl.handle.net/11424/246792
dc.language.isoeng
dc.relation.ispartofMetabolic Syndrome and Related Disorders
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleInsulin resistance, adipocyte biology, and thiazolidinediones: A review
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage115
oaire.citation.issue2
oaire.citation.startPage103
oaire.citation.titleMetabolic Syndrome and Related Disorders
oaire.citation.volume5

Files